Global Orally Disintegrating Tablet Excipient Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Global Orally Disintegrating Tablet Excipient Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

An orally disintegrating tablet or orally dissolving tablet (ODT) is a drug dosage form available for a limited range of over-the-counter (OTC) and prescription medications.An excipient is a pharmacologically inert adhesive substance used to bind the contents of a pill or tablet. This type of tablet separates in the mouth in contact with saliva, making it easy for a person to swallow the tablet without drinking water.

According to our (Global Info Research) latest study, the global Orally Disintegrating Tablet Excipient market size was valued at US$ 17780 million in 2023 and is forecast to a readjusted size of USD 22440 million by 2030 with a CAGR of 3.4% during review period.

McePharma (Vivesa holding) was the global greatest company in Orally Disintegrating Tablet Excipient industry, with the revenue market Share of 3% , followed by BASF, JRS Pharma, Roquette, ABF Ingredients, DFE Pharma, Evonik, Merck KGaA, Ashland, Meggle Pharma, Shin-Etsu, Fuji Chemical Industries, Cargill Incorporated, Daicel Corporation, Anhui Sunhere Pharmaceutical.APAC is the largest Orally Disintegrating Tablet Excipient market with about 30% market share. Americas is follower, accounting for about 27% market share.

This report is a detailed and comprehensive analysis for global Orally Disintegrating Tablet Excipient market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2024, are provided.

Key Features:

Global Orally Disintegrating Tablet Excipient market size and forecasts, in consumption value ($ Million), sales quantity (K MT), and average selling prices (USD/MT), 2019-2030

Global Orally Disintegrating Tablet Excipient market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K MT), and average selling prices (USD/MT), 2019-2030

Global Orally Disintegrating Tablet Excipient market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K MT), and average selling prices (USD/MT), 2019-2030

Global Orally Disintegrating Tablet Excipient market shares of main players, shipments in revenue ($ Million), sales quantity (K MT), and ASP (USD/MT), 2019-2024

The Primary Objectives in This Report Are:

To determine the size of the total market opportunity of global and key countries

To assess the growth potential for Orally Disintegrating Tablet Excipient

To forecast future growth in each product and end-use market

To assess competitive factors affecting the marketplace

This report profiles key players in the global Orally Disintegrating Tablet Excipient market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include BASF, JRS Pharma, Roquette, ABF Ingredients, DFE Pharma, Evonik, Merck KGaA, Ashland, Meggle Pharma, Shin-Etsu, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Market Segmentation

Orally Disintegrating Tablet Excipient market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
Binders
Glidents
Diluents
Disintegrants
Others

Market segment by Application
Anti-Psychotics Drug
Anti-Epileptics Drug
Others

Major players covered
BASF
JRS Pharma
Roquette
ABF Ingredients
DFE Pharma
Evonik
Merck KGaA
Ashland
Meggle Pharma
Shin-Etsu
Fuji Chemical Industries
McePharma (Vivesa holding)
Cargill Incorporated
Daicel Corporation
Anhui Sunhere Pharmaceutical

Market segment by region, regional analysis covers

North America (United States, Canada, and Mexico)

Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)

South America (Brazil, Argentina, Colombia, and Rest of South America)

Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:

Chapter 1, to describe Orally Disintegrating Tablet Excipient product scope, market overview, market estimation caveats and base year.

Chapter 2, to profile the top manufacturers of Orally Disintegrating Tablet Excipient, with price, sales quantity, revenue, and global market share of Orally Disintegrating Tablet Excipient from 2019 to 2024.

Chapter 3, the Orally Disintegrating Tablet Excipient competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Orally Disintegrating Tablet Excipient breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2019 to 2030.

Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2019 to 2030.

Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2019 to 2024.and Orally Disintegrating Tablet Excipient market forecast, by regions, by Type, and by Application, with sales and revenue, from 2025 to 2030.

Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.

Chapter 13, the key raw materials and key suppliers, and industry chain of Orally Disintegrating Tablet Excipient.

Chapter 14 and 15, to describe Orally Disintegrating Tablet Excipient sales channel, distributors, customers, research findings and conclusion.